Research output per year
Research output per year
Research activity per year
Nico Wulffraat is professor of pediatric Rheumatology at the department of pediatrics, University Medical Center, Utrecht, The Netherlands. He obtained his MD and PhD (1987) at the Free University Hospital Amsterdam. He trained as a paediatrician from 1988 untill 1993 in Utrecht. He was fellow pediatric immunology and rheumatology from 1993 to 1995 in the WKZ. Since 1995 he worked as a consultant in pediatric immunology-rheumatology. Since 2010 he is the head of this subunit. From 1997-2004 he was also coordinator of the pediatric allogeneic and autologous stem cell transplantations for immune deficiencies, metabolic disorders and autoimmune diseases. He is PI of several investigator initiated trials of immunisations in children with rheumatic diseases including MMR, HPV and Men C, prevention of MTX side effects, and application of Mesenchymal Stem cells in refractory GvHD and JIA. He is coordinator of a FP7 consortium for pharmacovigilance of biologics used in JIA (PHARMACHILD). Also he leads the EHHC project SHARE that aims at documenting standards of care and treatment recommendations for pediatric rheumatic diseases throughout Europe.
Since 2008 he became supervisor of the postgraduate clinical fellowship pediatric rheumatology and since 2009 head of pediatric immunology and rheumatology. In 2014, he was appointed as head of pediatric Rheumatology, Immunology, hematology and infectious diseases.
He has co-authored 220 Pubmed cited papers in international journals on pediatric rheumatology and immunology and 12 chapters in books.
Committees:
Gezondheidsraad advies CVS
ZonMW commissie programma translationeel onderzoek en adulte stamcellen, adviesgroep medische producten (2009-2016)
Evaluatie beoordeling NFU expertise centra
Council PRES (2004-2010)
Council PRINTO National representative for NL (2001-2014)
ERN RITA HCP Member Representative (2017) and since 2019 ERN RITA coordinator
Reviewer for all major rheumatology Journals, Blood, Lancet, NEJM
Memberships:
Member of EBMT working party for autoimmune diseases (Chair R Saccardi, Florence Italy)
Member of the ZONWM programme committee Translational Adult Stem cell research
Member of Advisory working group consisting of external experts for RIVM (Corona related) (2021- )
Member of the European Medicines Agency (EMA) expert group for pediatric rheumatology
Member of the ZONMW programme committee Priority medicines for children
Member of the advisory council Ter Meulen Fonds
Member of the Drug Safety Monitoring board of the adalumimab trial for uveitis (NHS, England)
Member of the board for the Dutch pediatric rheumatology society, for education and research (2001-2010)
Member of the board for Utrecht pediatric postgraduate courses (1999-2010)
Member of the Scientific Advisory Council of the Dutch League for Rheumatology (Nationaal Reumafonds, 2006-2009)
Member of the Utrecht study group for the development of the electronic patient file into clinical paractise (2005-2009)
Member of the EBMT working party for inborn errors and immunodeficiencies (1996-2008)
Potential Conflicts of Interest
Dr. Wulffraat has regular interaction with pharmaceutical and other industrial partners. These activities were continued until 2018 . Since then he is the chair of the European rare Diseases Network (RITA) and receives grants from the EU to sustain this network. As per may 2022 he will receive a part time salary for this. ERN RITA has supported international clinical practice guidelines. UMCU has received incidental funding (up to €10,000 as multi sponsoring per event as support for research and educational activities deployed by the Pediatric Rheumatology European Society. This is a non-for profit organization. He has received support from the Dutch medical Insurance company het Zilveren Kruis for a study on the use of an App (as a medical device) specifically for patients with chronic arthritis
FP7 Grant Pharmachild
AEMC Grant SHARE
Div. ZON MW Grants
UCAN CANDU
Foreum
AbbVie (bijdrage Reuma2Go)
Roche (bijdrage Reuma2Go)
ERN coordinator RITA
ZonMW grant Chronic Fatique QFS and JIA
chair of the European rare Diseases Network (RITA) - Clinical & Research expertise - The European Reference Network
1 May 2022 → 31 Dec 3999
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Nico M. Wulffraat (Chair)
Activity: Membership › Membership of committee › Academic
Nico M. Wulffraat (Participant)
Activity: Participating in or organising an event › Participation in conference › Academic
Nico M. Wulffraat (Interviewee)
Activity: Other › Types of Public engagement and outreach - Media article or participation
Nico M. Wulffraat (Interviewee)
Activity: Other › Types of Public engagement and outreach - Media article or participation
Nico M. Wulffraat (Participant)
Activity: Participating in or organising an event › Participation in conference › Academic
12/12/17
1 Media contribution
Press/Media: Expert Comment
1/12/17
1 Media contribution
Press/Media: Expert Comment
1/11/17
1 Media contribution
Press/Media: Expert Comment
Nico M. Wulffraat, JF Swart & SJ Vastert
1/04/17
1 Media contribution
Press/Media: Expert Comment
17/02/17
1 Media contribution
Press/Media: Expert Comment